Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vanhauwaert, A.
Right arrow Articles by Kirsch-Volders, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanhauwaert, A.
Right arrow Articles by Kirsch-Volders, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis, Vol. 16, No. 1, 39-50, January 2001
© 2001 UK Environmental Mutagen Society/Oxford University Press

The in vivo gut micronucleus test detects clastogens and aneugens given by gavage

Annelies Vanhauwaert1, Philippe Vanparys2 and Micheline Kirsch-Volders1,3

1 Laboratory for Cell Genetics, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels and 2 Laboratory for Genetic and In Vitro Toxicology, Janssen Research Foundation, B-2340 Beerse, Belgium

A general testing battery for pharmaceuticals includes a bacterial gene mutation assay, an in vitro chromosomal aberration or a gene mutation test on mammalian cells and an in vivo test for chromosome/genome mutations. The aim of this study was to determine whether the in vivo mouse gut micronucleus assay could be a more sensitive method to detect direct clastogens and/or aneugens given orally by gavage than the in vivo bone marrow micronucleus assay (which can also detect indirect genotoxins). Two laboratories collaborated in this project, one analysing bone marrow cells and the other analysing gut cells from the same animals. The reference substances tested in this study were colchicine (COL), carbendazim (CAR), tubulazole (TUB) and griseofulvin (GRI), all known aneugens, and 1,2-dimethylhydrazine (DMH), a colon carcinogen with clastogenic activity. For all substances tested, the in vivo gut micronucleus test was as sensitive as or more sensitive than the in vivo bone marrow micronucleus assay: COL and TUB induced micronuclei in both gut and bone marrow cells; DMH, CAR and GRI induced micronuclei only in gut cells. The results show that the micronucleus test on gut cells is able to detect clastogens and aneugens given orally by gavage, some of which were not detected by the bone marrow micronucleus test.

3 To whom correspondence should be addressed. Email: mkirschv{at}vub.ac.be


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
A. Celik, B. Mazmanci, Y. Camlica, A. Askin, and U. Comelekoglu
Induction of micronuclei by lambda-cyhalothrin in Wistar rat bone marrow and gut epithelial cells
Mutagenesis, March 1, 2005; 20(2): 125 - 129.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. De Boeck, P. Hoet, N. Lombaert, B. Nemery, M. Kirsch-Volders, and D. Lison
In vivo genotoxicity of hard metal dust: induction of micronuclei in rat type II epithelial lung cells
Carcinogenesis, November 1, 2003; 24(11): 1793 - 1800.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
F. Pacchierotti, B. Bassani, F. Marchetti, and C. Tiveron
Griseofulvin induces mitotic delay and aneuploidy in bone marrow cells of orally treated mice
Mutagenesis, May 1, 2002; 17(3): 219 - 222.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.